Reactive Myelopoiesis and the Onset of Myeloid-mediated Immune Suppression: Implications for Adoptive Cell Therapy

Overview

Journal Cell Immunol

Publisher Elsevier

Specialties Allergy & Immunology
Cell Biology

Date 2021 Jan 21

PMID 33476931

Citations 4

Authors

Patrick Innamarato

Shari Pilon-Thomas

Affiliations

Soon will be listed here.

Abstract

Adoptive T cell therapy (ACT) in combination with lymphodepleting chemotherapy is an effective strategy to induce the eradication of cancer, providing long-term regressions in patients. However, only a minority of patients that receive ACT with tumor-specific T cells exhibit durable benefit. Thus, there is an urgent need to characterize mechanisms of resistance and define strategies to alleviate immunosuppression in the context of ACT in cancer. This article reviews the importance of lymphodepleting regimens in promoting the optimal engraftment and expansion of T cells in hosts after adoptive transfer. In addition, we discuss the role of concomitant immunosuppression and the accumulation of myeloid derived suppressor cells (MDSCs) during immune recovery after lymphodepleting regimens and mobilization regimens.

Citing Articles

Cancer immunotherapy and its facilitation by nanomedicine.

Sui C, Wu H, Li X, Wang Y, Wei J, Yu J Biomark Res. 2024; 12(1):77.

PMID: 39097732 PMC: 11297660. DOI: 10.1186/s40364-024-00625-6.

Immunosuppressive regulatory cells in cancer immunotherapy: restrain or modulate?.

Wu Y, Chen D, Gao Y, Xu Q, Zhou Y, Ni Z Hum Cell. 2024; 37(4):931-943.

PMID: 38814516 DOI: 10.1007/s13577-024-01083-w.

Reactive myelopoiesis and FX-expressing macrophages triggered by chemotherapy promote cancer lung metastasis.

Wu C, Zhong Q, Shrestha R, Wang J, Hu X, Li H JCI Insight. 2023; 8(9).

PMID: 36976637 PMC: 10243818. DOI: 10.1172/jci.insight.167499.

Tumor MHC class I expression alters cancer-associated myelopoiesis driven by host NK cells.

Neo S, Jing X, Tong L, Tong D, Gao J, Chen Z J Immunother Cancer. 2022; 10(10).

PMID: 36283735 PMC: 9608525. DOI: 10.1136/jitc-2022-005308.

References

Cain D, Snowden P, Sempowski G, Kelsoe G . Inflammation triggers emergency granulopoiesis through a density-dependent feedback mechanism. PLoS One. 2011; 6(5):e19957. PMC: 3104996. DOI: 10.1371/journal.pone.0019957. View

Little M, Storb R . History of haematopoietic stem-cell transplantation. Nat Rev Cancer. 2002; 2(3):231-8. DOI: 10.1038/nrc748. View

Wilson A, Trumpp A . Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol. 2006; 6(2):93-106. DOI: 10.1038/nri1779. View

Kawakami M, Tsutsumi H, Kumakawa T, Abe H, Hirai M, Kurosawa S . Levels of serum granulocyte colony-stimulating factor in patients with infections. Blood. 1990; 76(10):1962-4. View

Wu L, Liu H, Guo H, Wu Q, Yu S, Qin Y . Circulating and tumor-infiltrating myeloid-derived suppressor cells in cervical carcinoma patients. Oncol Lett. 2018; 15(6):9507-9515. PMC: 5958827. DOI: 10.3892/ol.2018.8532. View

Rosenberg S . IL-2: the first effective immunotherapy for human cancer. J Immunol. 2014; 192(12):5451-8. PMC: 6293462. DOI: 10.4049/jimmunol.1490019. View

Verschoor C, Johnstone J, Millar J, Dorrington M, Habibagahi M, Lelic A . Blood CD33(+)HLA-DR(-) myeloid-derived suppressor cells are increased with age and a history of cancer. J Leukoc Biol. 2013; 93(4):633-7. PMC: 3701116. DOI: 10.1189/jlb.0912461. View

Sistigu A, Yamazaki T, Vacchelli E, Chaba K, Enot D, Adam J . Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. Nat Med. 2014; 20(11):1301-9. DOI: 10.1038/nm.3708. View

Lieschke G, Grail D, Hodgson G, Metcalf D, Stanley E, Cheers C . Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood. 1994; 84(6):1737-46. View

10.

Gattinoni L, Finkelstein S, Klebanoff C, Antony P, Palmer D, Spiess P . Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells. J Exp Med. 2005; 202(7):907-12. PMC: 1397916. DOI: 10.1084/jem.20050732. View

11.

Kuczma M, Ding Z, Li T, Habtetsion T, Chen T, Hao Z . The impact of antibiotic usage on the efficacy of chemoimmunotherapy is contingent on the source of tumor-reactive T cells. Oncotarget. 2018; 8(67):111931-111942. PMC: 5762370. DOI: 10.18632/oncotarget.22953. View

12.

Neitzke D, Bowers J, Andrijauskaite K, OConnell N, Garrett-Mayer E, Wrangle J . Murine Th17 cells utilize IL-2 receptor gamma chain cytokines but are resistant to cytokine withdrawal-induced apoptosis. Cancer Immunol Immunother. 2017; 66(6):737-751. PMC: 5679708. DOI: 10.1007/s00262-017-1965-3. View

13.

Alshetaiwi H, Pervolarakis N, McIntyre L, Ma D, Nguyen Q, Rath J . Defining the emergence of myeloid-derived suppressor cells in breast cancer using single-cell transcriptomics. Sci Immunol. 2020; 5(44). PMC: 7219211. DOI: 10.1126/sciimmunol.aay6017. View

14.

Dudley M, Wunderlich J, Robbins P, Yang J, Hwu P, Schwartzentruber D . Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science. 2002; 298(5594):850-4. PMC: 1764179. DOI: 10.1126/science.1076514. View

15.

Huang B, Pan P, Li Q, Sato A, Levy D, Bromberg J . Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 2006; 66(2):1123-31. DOI: 10.1158/0008-5472.CAN-05-1299. View

16.

Bunt S, Yang L, Sinha P, Clements V, Leips J, Ostrand-Rosenberg S . Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res. 2007; 67(20):10019-26. PMC: 4402704. DOI: 10.1158/0008-5472.CAN-07-2354. View

17.

Finlay B, Goldszmid R, Honda K, Trinchieri G, Wargo J, Zitvogel L . Can we harness the microbiota to enhance the efficacy of cancer immunotherapy?. Nat Rev Immunol. 2020; 20(9):522-528. DOI: 10.1038/s41577-020-0374-6. View

18.

Arpinati M, Green C, Heimfeld S, Heuser J, Anasetti C . Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood. 2001; 95(8):2484-90. View

19.

Kwak H, Liu P, Bajrami B, Xu Y, Park S, Nombela-Arrieta C . Myeloid cell-derived reactive oxygen species externally regulate the proliferation of myeloid progenitors in emergency granulopoiesis. Immunity. 2015; 42(1):159-71. PMC: 4303526. DOI: 10.1016/j.immuni.2014.12.017. View

20.

Hirayama A, Gauthier J, Hay K, Voutsinas J, Wu Q, Gooley T . The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells. Blood. 2019; 133(17):1876-1887. PMC: 6484391. DOI: 10.1182/blood-2018-11-887067. View